A comparison of strategic IR with plain vanilla IR
Every industry has its buzzwords that spread like wildfire. The healthcare industry has stem cell research, the technology space has fiber optics, and the bioethics industry - a buzzword in itself - has genomics. In the world of investor relations, the buzzword gaining a lot of speed these days is strategic IR. Ever since the market took a nosedive, IROs have been using the term strategic investor relations - rather than plain old investor relations - to describe what they do. The trouble
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
